Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes (Agarwal et al, Annals IM 2023)
Freely Filtered 28: Fidelio with Burgner and Bakris
The Filtrate welcome Drs. Anna Burgner and George Bakris to discuss the breakthrough clinical trial FIDELIO and the non-steroidal aldosteropne antagonist, finerenone.
Visual abstract for FIDELIO
Beautiful visual abstract by Dhwanil Patel